A minority of AD patients have an early onset, genetic, familial form of AD due to autosomal dominant mutations in amyloid β precursor protein (AβPP), presenilin-1 (PS1), and presenilin-2 (PS2) [16]. Here, PSEN1 is linked to Alzheimer disease.